Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Co. has developed Micro-Invasive Glaucoma Surgery as an alternative to the glaucoma treatment paradigm, a bio-activated pharmaceutical therapy for the treatment of a corneal disorder, keratoconus, as well as a pipeline of sustained pharmaceutical therapies, surgical devices, and implantable biosensors to treat glaucoma progression, corneal disorders such as keratoconus, dry eye and refractive vision correction, and retinal diseases such as neovascular age-related macular degeneration and retinal vein occlusion. We show 36 historical shares outstanding datapoints in our GKOS shares outstanding history coverage, used to compute GKOS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GKOS market cap history over the course of time is important for investors
interested in comparing GKOS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GKOS versus a peer is one thing; comparing
GKOS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GKOS can fluctuate over the course of history.
With this page we aim to empower investors researching GKOS by allowing them to research the GKOS market cap history. |
Free GKOS Email Alerts:
Video: The Importance of Market Cap
